TD Cowen maintains Calumet at Hold, lowers price target to $37 from $40
TD Cowen kept its Hold rating on Calumet but reduced its price target from $40 to $37, a 7.5% cut. This new target suggests a 16.3% upside from the Nov 17 closing price of $31.82, according to the firm.

